A heavily anticipated initial public offering (IPO) from Tilray finally made its debut on the Nasdaq with a higher price tag than expected on Thursday (July 19). During its first day in the public market, Tilray’s stock delivered on the anticipation from the investor audience with an offering size of approximately US$153 million. The offering is expected to complete on July 23. The cannabis producer started offering 9 million shares with an initial price tag of US$23.05 each–an increase from the original plan to sell between US$14 and US$16. At the end of Thursday’s trading session TLRY was worth US$22.39 per share. Tilray will trade its class 2 common stock shares with subordinate voting power under the ticker symbol “TLRY.” The producer’s parent company Privateer Holdings, a private equity firm based in Seattle, holds all of the multiple-voting shares, according to The Globe and Mail.

Hemp Land, Cannabis Hemp Blog, 04/09/2021 07:56:00

Open article: https://hempland.net/tilray-makes-public-debut-worth-us153-million/

Canopy Growth Corporation nd The Supreme Cannabis Company, Inc announced that they have entered into a definitive arrangement agreement under which Canopy will acquire all of Supreme Cannabis’ issued and outstanding common shares (the “Supreme Cannabis Shares”) in a transaction valued at approximately $435 million on a fully-diluted basis. Under the terms of the Arrangement Agreement, Supreme Cannabis shareholders will receive 0.01165872 of a Canopy common share and $0.0001 in cash in exchange for each Supreme Cannabis Share held. The Transaction provides Supreme Cannabis shareholders with a premium per Supreme Cannabis Share of approximately 66% based on the closing prices of the Supreme Cannabis Shares and Canopy common shares on the Toronto Stock Exchange as of April 7, 2021. The Transaction is expected to provide several benefits to both Canopy and Supreme Cannabis shareholders.

Published Ncv Newswire, New Cannabis Ventures, 04/08/2021 08:46:00

Open article: https://www.newcannabisventures.com/canopy-growth-to-acquire-supreme-cannabis-for-435-million-in-stock/

Curaleaf Holdings, Inc. (OTCQX: CURLF) has successfully completed the previously announced acquisition of the European-based EMMAC Life Sciences Limited, a deal valued at approximately $50 million in cash and 17.5 million shares of Curaleaf. Curaleaf has simultaneously established Curaleaf International Holdings Limited in Guernsey to hold the EMMAC investment and further its European expansion. In order to speed up the process of expanding Curaleaf International, Curaleaf said it has secured an investment of $130 million from a single strategic institutional investor in exchange for a 31.5% equity stake in Curaleaf International, implying a $413 million Post Money valuation, with $80 million in cash available to spend. The company said that the subscription will fund the entire cash portion of the EMMAC acquisition consideration of $50 million with the remaining $80 million to be used to fund Curaleaf International’s current capital expenditures plan through 2022, as well as its pipeline of potential acquisitions.

Sean Hocking, Cannabis Law Report, 04/07/2021 14:37:00

Open article: https://cannabislaw.report/curaleaf-closes-emmac-deal-raises-130-million-for-expansion/